Notice Number: NOT-CA-18-035

Key Dates
Release Date: January 24, 2018

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct Part 2. Full Text of Announcement, Section I. Funding Opportunity Description and Section III. Eligibility Information, 3. Additional Information on Eligibility, Number of Applications in PA-18-517, "Innovation Corps (I-Corps ) at NIH Program for NIH and CDC Translational Research (Admin Supp - Clinical Trial Not Allowed)".

Part 2. Full Text of Announcement
Section I. Funding Opportunity Description

Currently reads:
The NIH anticipates that applicants receiving administrative supplements under this FOA will be enrolled in the I-Corps at NIH Program in the first of two cohorts in 2018. Only one cohort is invited through this FOA.

Should correctly read (in italics):
The NIH anticipates that applicants receiving administrative supplements under this FOA will be enrolled in the I-Corps at NIH Program in the second of two cohorts in 2018. Only one cohort is invited through this FOA.

Section III. Eligibility Information
3. Additional Information on Eligibility, Number of Applications

Currently reads:
Only one supplement application per parent SBIR/STTR Phase I award is allowed under this FOA. Applicant organizations with multiple, currently-active SBIR and/or STTR Phase I awards from the different participating Institutes and Centers listed on this FOA may choose only ONE award to serve as the predicate for an administrative supplement to support the I-Corps at NIH program activity. The NIH and CDC will not fund multiple administrative supplement awards to the same applicant organization under this FOA.

To apply for an administrative supplement award under this FOA, applicants must have received a prior SBIR or STTR Phase I grant from one of the participating ICs. The predicate Phase I grant must extend (at least) through June 1, 2018, and the grant should have remaining budget and R&D activities that extend at least until that date. Grant awards currently under a no-cost extension are eligible, provided they meet the above criteria.

Should correctly read (in italics):

Only one supplement application per parent SBIR/STTR Phase I award is allowed under this FOA. Applicant organizations with multiple, currently-active SBIR and/or STTR Phase I awards from the different participating Institutes and Centers listed on this FOA may choose only ONE award to serve as the predicate for an administrative supplement to support the I-Corps at NIH program activity. The NIH and CDC will not fund multiple administrative supplement awards to the same applicant organization under this FOA.

To apply for an administrative supplement award under this FOA, applicants must have received a prior SBIR or STTR Phase I grant from one of the participating ICs. The predicate Phase I grant must extend (at least) through August 14, 2018, and the grant should have remaining budget and R&D activities that extend at least until that date. Grant awards currently under a no-cost extension are eligible, provided they meet the above criteria.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Christie Canaria, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5720
Email: [email protected]